Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS ...
Masimo has announced collaboration with Google and Qualcomm to build a smartwatch reference platform for OEMs to use. Read on ...
Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health ...
New Wear OS watches will get health upgrades from the company that almost got the Apple Watch banned
With the help of Google, Masimo, a health tech giant, is building a new reference platform with upgraded health tracking on Wear OS.
Masimo will partner with Google to develop a new reference platform for original equipment manufacturers (OEMs) building Wear OS by Google smartwatches.
The Masimo W1 Sport will be the first reference platform ... violating patents for blood oxygen tracking technology in Apple Watches. Masimo was willing to reach a licensing deal with Apple ...
Courts blocked Apple from enabling blood oxygen sensors in the Apple Watch due to patent infringement on medical device company Masimo, which holds over 1,500 medical technology patents.
Masimo (NASDAQ:MASI) partners with Google (GOOG) to develop a new reference platform for original equipment manufacturers ((OEMs)) building Wear OS by Google smartwatches. OEMs who adopt the new ...
Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.
Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund Politan Capital Management, in one of the most contentious boardroom battles ...
such as Rad-97® and the Masimo W1® medical watch. Masimo hospital and home automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback